AU559082B2 - Process for producing alkylangelicins free from psoralens - Google Patents

Process for producing alkylangelicins free from psoralens

Info

Publication number
AU559082B2
AU559082B2 AU20141/83A AU2014183A AU559082B2 AU 559082 B2 AU559082 B2 AU 559082B2 AU 20141/83 A AU20141/83 A AU 20141/83A AU 2014183 A AU2014183 A AU 2014183A AU 559082 B2 AU559082 B2 AU 559082B2
Authority
AU
Australia
Prior art keywords
alkylangelicins
psoralens
producing
free
producing alkylangelicins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU20141/83A
Other versions
AU2014183A (en
Inventor
Francesco Carl Assare
Francarosa Baccichetti
Franco Bordin
Carlo Monte Bracadin
Mario Cristofolini
Francesco Dall'acqua
Adriano Guitto
Giovanni Pastorini
Giovanni Recchia
Giovanni Rodighiero
Paolo Rodighiero
Daniela Vedaldi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consiglio Nazionale delle Richerche CNR
Original Assignee
Consiglio Nazionale delle Richerche CNR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale delle Richerche CNR filed Critical Consiglio Nazionale delle Richerche CNR
Publication of AU2014183A publication Critical patent/AU2014183A/en
Application granted granted Critical
Publication of AU559082B2 publication Critical patent/AU559082B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU20141/83A 1982-10-18 1983-10-13 Process for producing alkylangelicins free from psoralens Ceased AU559082B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT84148/82 1982-10-18
IT84148/82A IT1165797B (en) 1982-10-18 1982-10-18 PREPARATION PROCESS FOR ALCHYLANGELICINS FREE OF PSORALENES AND ALCHYLANGOLICINS OBTAINED BY THE PROCEDURE

Publications (2)

Publication Number Publication Date
AU2014183A AU2014183A (en) 1984-05-03
AU559082B2 true AU559082B2 (en) 1987-02-19

Family

ID=11324788

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20141/83A Ceased AU559082B2 (en) 1982-10-18 1983-10-13 Process for producing alkylangelicins free from psoralens

Country Status (12)

Country Link
US (1) US5001147A (en)
JP (1) JPH0633269B2 (en)
AT (1) AT384810B (en)
AU (1) AU559082B2 (en)
CA (1) CA1228860A (en)
CH (1) CH662566A5 (en)
DE (1) DE3337207A1 (en)
ES (1) ES8608523A1 (en)
FR (1) FR2534585B1 (en)
GB (1) GB2128997B (en)
IT (1) IT1165797B (en)
ZA (1) ZA837585B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1402632A (en) * 1999-12-23 2003-03-12 辉瑞产品公司 Hydrogel-driven drug dosage form
JP5230420B2 (en) * 2005-08-18 2013-07-10 ゲンマブ エー/エス Treatment with CD4 binding peptides and radiation
ITVE20070005A1 (en) 2007-01-25 2008-07-26 Associazione Veneta Per La Lotta Alla Talassemia DRUG FOR THE TREATMENT OF TALASSEMIA, FALCIFORM ANEMIA AND ALL THE OTHER FORMS OF ANEMIA TREATABLE WITH THIS, DRUG ACTIVATION METHOD, PHARMACEUTICAL COMPOSITION AS AN ACTIVE PRINCIPLE THE DRUG AND PHOTOCHEMIOTHERAPY METHOD U
CN102177162B (en) 2008-10-21 2015-02-11 花王株式会社 NFAT signal inhibitor and hair-growing agent
CN105832720B (en) * 2016-05-03 2019-04-05 中国科学院新疆理化技术研究所 A kind of purposes of Psoralens resistance compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI59598C (en) * 1977-10-03 1981-09-10 Star Oy Ab NYTT FOERFARANDE FOER FRAMSTAELLNING AV I 9-STAELLNINGEN EVENTUELLT METOXISUBSTITUERADE 7H-FURO (3,2-G) (1) BENSOPYRAN-7-ONER
JPS55124775A (en) * 1979-03-13 1980-09-26 Elder Thomas C Inc Alphaalower alkylfurocoumarin manufacture and intermediate oftained therefrom
US4216154A (en) * 1979-03-15 1980-08-05 Thomas C. Elder, Inc. Process for making α-loweralkylfurocoumarins
IT1166343B (en) * 1979-08-20 1987-04-29 Francarosa Baccichetti FUROCUMARINE FOR THE PHOTOCHEMOTHERAPY OF FSORIASIS AND OTHER SENSITIVE SKIN DISEASES

Also Published As

Publication number Publication date
CA1228860A (en) 1987-11-03
GB2128997B (en) 1985-12-24
JPH0633269B2 (en) 1994-05-02
IT8284148A0 (en) 1982-10-18
GB2128997A (en) 1984-05-10
ZA837585B (en) 1984-06-27
US5001147A (en) 1991-03-19
DE3337207C2 (en) 1991-12-19
ES8608523A1 (en) 1986-07-16
ATA370383A (en) 1987-06-15
CH662566A5 (en) 1987-10-15
JPS59104387A (en) 1984-06-16
GB8327200D0 (en) 1983-11-09
AT384810B (en) 1988-01-11
DE3337207A1 (en) 1984-04-19
FR2534585B1 (en) 1986-12-19
FR2534585A1 (en) 1984-04-20
IT1165797B (en) 1987-04-29
ES526910A0 (en) 1986-07-16
AU2014183A (en) 1984-05-03

Similar Documents

Publication Publication Date Title
AU557361B2 (en) Dehydrohalogenation process
AU546829B2 (en) Process for producing hydrocarbons
AU1425883A (en) Polymerisation process
DE3373093D1 (en) Process for producing aminophenyl-beta-hydroxyethylsulfone
AU557664B2 (en) Deposition process
AU566386B2 (en) Process for producing alcohols
AU563695B2 (en) A process for preparing substituted polycycloalkylidene polycyclo-alkanes
AU1254883A (en) Deoxygenation process
AU567786B2 (en) Calalytic process
AU6800481A (en) Process for producing aspartame
AU559082B2 (en) Process for producing alkylangelicins free from psoralens
HUT35271A (en) Process for producing antracycline-glycosides
AU555457B2 (en) Process for preparing trifluoracetyl chloride
DE3371902D1 (en) Process for producing isoprene
AU554999B2 (en) Process for n-phosphonomethylglycine
DE3369678D1 (en) Process for producing benzophenone-azines
DE3362699D1 (en) Process for producing alpha-acetoxypropionaldehyde
AU2791889A (en) Process for producing aminoaryl-beta-sulphatoethylsulphone compounds
HUT34440A (en) Improved process for producing azetidinone-sulfinacids from cephalosporin-sulfones
DE3370616D1 (en) Process for producing phenylacetones
AU571591B2 (en) Process for producing 9-carbamoyl fluorene derivatives
YU43536B (en) Process for producing new anthracyclinic glicosides
DE3160785D1 (en) Process for producing benzophenone-azines
IL62712A0 (en) Process for producing tolylthiourea having high purity
DE3269081D1 (en) Process for producing fluorobenzophenone derivatives